[Code of Federal Regulations]
[Title 21, Volume 5]
[Revised as of April 1, 2006]
From the U.S. Government Printing Office via GPO Access
[CITE: 21CFR358.101]

[Page 308-309]
 
                        TITLE 21--FOOD AND DRUGS
 
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN 
                          SERVICES (CONTINUED)
 
PART 358_MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN 
USE--Table of Contents
 
                  Subpart B_Wart Remover Drug Products
 
Sec.  358.101  Scope.




Subpart A [Reserved]

                  Subpart B_Wart Remover Drug Products

Sec.
358.101 Scope.
358.103 Definitions.
358.110 Wart remover active ingredients.
358.150 Labeling of wart remover drug products.

Subpart C [Reserved]

             Subpart D_Ingrown Toenail Relief Drug Products

358.301 Scope.
358.303 Definitions.
358.310 Ingrown toenail relief active ingredient.
358.350 Labeling of ingrown toenail relief drug products.

Subpart E [Reserved]

             Subpart F_Corn and Callus Remover Drug Products

358.501 Scope.
358.503 Definitions.
358.510 Corn and callus remover active ingredients.

[[Page 309]]

358.550 Labeling of corn and callus remover drug products.

                  Subpart G_Pediculicide Drug Products

358.601 Scope.
358.603 Definition.
358.610 Pediculicide active ingredients.
358.650 Labeling of pediculicide drug products.

    Subpart H_Drug Products for the Control of Dandruff, Seborrheic 
                        Dermatitis, and Psoriasis

358.701 Scope.
358.703 Definitions.
358.710 Active ingredients for the control of dandruff, seborrheic 
          dermatitis, or psoriasis.
358.720 Permitted combinations of active ingredients.
358.750 Labeling of drug products for the control of dandruff, 
          seborrheic dermatitis, or psoriasis.

    Authority: 21 U.S.C. 321, 351, 352, 353, 355, 360, 371.

    Source: 55 FR 33255, Aug. 14, 1990, unless otherwise noted.

Subpart A [Reserved]



    (a) An over-the-counter wart remover drug product in a form suitable 
for topical application is generally recognized as safe and effective 
and is not misbranded if it meets each of the conditions in this subpart 
and each of the general conditions established in Sec.  330.1 of this 
chapter.
    (b) References in this subpart to regulatory sections of the Code of 
Federal Regulations are to chapter I of title 21 unless otherwise noted.